drugset / Trial / NCT04854486

Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients

NCT04854486

Phase 3 Withdrawn Larkin Community Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

This clinical trial aims to ascertain the impact of GSE and Xylitol (XLEAR) in decreasing the time of negativisation in PCR testing in patients with COVID-19.

Timeline

Start
2021-12-16
Primary completion
2022-03-30
Completion
2022-11-16

Drugs

EvaluationDrugModalityDoseRoute
Subject GSE Unknown
Subject Xylitol Small molecule

Indications